SPR Therapeutics LOGO 361 TM.jpg
Study of Sprint Peripheral Nerve Stimulation System Demonstrates 12 Months of Low Back Pain Relief Following 60-Day Treatment
21 janv. 2020 08h55 HE | SPR Therapeutics, Inc.
CLEVELAND, Jan. 21, 2020 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, today announced publication of a prospective case series regarding...
SPRINT PNS MicroLead held by physician
Study Demonstrates 12-Month Relief of Post-Amputation Pain Following Treatment With SPRINT PNS System
10 déc. 2019 08h29 HE | SPR Therapeutics, Inc.
CLEVELAND, Dec. 10, 2019 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, today announced publication of 12-month follow up results of its...
SPRINT PNS MicroLead
SPR Therapeutics Announces 1000th Sprint PNS Procedure
04 déc. 2019 08h30 HE | SPR Therapeutics, Inc.
CLEVELAND, Dec. 04, 2019 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, announced today the successful commercial placement of its 1000th...
logo with a transparent background.png
Montu Group Launches Medical Cannabis Brand Circle Into Australian Market
28 nov. 2019 15h00 HE | Montu Group Pty Ltd
MELBOURNE, Australia, Nov. 29, 2019 (GLOBE NEWSWIRE) -- Montu Group Pty. Ltd (“Montu Group” or the “Company”), a leading medical cannabis company with presence in Europe and Asia-Pacific, is pleased...
AptinyxLogo_FullColor_RGB.jpg
Aptinyx to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019
05 nov. 2019 08h07 HE | Aptinyx Inc.
EVANSTON, Ill., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and...
ADYNXX_CLEAR.png
Adynxx Receives NIH HEAL Initiative Funding Award for Development of Second Non-Opioid Pain Therapeutic
02 oct. 2019 08h00 HE | Adynxx, Inc.
SAN FRANCISCO, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (OTCQB: ADYX), a clinical-stage biopharmaceutical company focused on the development of transcription factor decoy technology and...
Allsup Supports U.S. Pain Foundation in Bringing Attention to Chronic Pain during National Pain Awareness Month
23 sept. 2019 11h57 HE | Allsup
Belleville, Illinois, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Allsup, the nation’s premier disability representation company, remains committed to supporting the significant contributions of the U.S....
BioDelivery Sciences logo
BioDelivery Sciences Announces Five Medical Abstracts Accepted at PAINWeek® 2019 National Conference on Pain Management
28 août 2019 07h45 HE | BioDelivery Sciences International, Inc.
RALEIGH, N.C., Aug. 28, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with chronic...
SPR Therapeutics LOGO 361 TM.jpg
SPR Therapeutics’ SPRINT Peripheral Nerve Stimulation System Significantly Reduces Opioid Use in Patients with Low Back Pain, Interim Data Show
21 août 2019 08h30 HE | SPR Therapeutics, Inc.
CLEVELAND, Ohio and KISSIMMEE, Florida, Aug. 21, 2019 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, presented interim results today on the...
Abt Expands Opioid Q
Abt Expands Opioid Quality Improvement Collaborative, Aims To Improve Chronic Pain Care
14 août 2019 11h06 HE | Abt Associates
Rockville, Md., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Abt Associates has expanded the Opioid Quality Improvement (QI) Collaborative launched in March 2018 to a second cohort of healthcare systems....